Influenza medical therapy: Difference between revisions

Jump to navigation Jump to search
(/* Antiviral Medications Recommended for Treatment and Chemoprophylaxis of Influenza Adapted from CDC {{cite web| url=http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm| title=CDC Influenza Antiviral Medications: Summary for Clini...)
Line 83: Line 83:
|}
|}


Children and teenagers with flu symptoms (particularly fever) should avoid taking [[aspirin]] as taking aspirin in the presence of influenza infection (especially [[Influenzavirus B]]) can lead to [[Reye's syndrome]], a rare but potentially fatal disease of the [[liver]].<ref>{{cite news  | last = Molotsky | first = Irvin | title = Consumer Saturday - Warning on Flu and Aspirin | publisher = New York Times | date = 1986-02-15 | url = http://query.nytimes.com/gst/fullpage.html?sec=health&res=9A0DEFD7133BF936A25751C0A960948260 | accessdate = 2007-05-25}}</ref>
* Children and teenagers with flu symptoms (particularly fever) should avoid taking [[aspirin]] as taking aspirin in the presence of influenza infection (especially [[Influenzavirus B]]) can lead to [[Reye's syndrome]], a rare but potentially fatal disease of the [[liver]].<ref>{{cite news  | last = Molotsky | first = Irvin | title = Consumer Saturday - Warning on Flu and Aspirin | publisher = New York Times | date = 1986-02-15 | url = http://query.nytimes.com/gst/fullpage.html?sec=health&res=9A0DEFD7133BF936A25751C0A960948260 | accessdate = 2007-05-25}}</ref>


===Unconventional treatment===
===Unconventional treatment===

Revision as of 15:24, 24 October 2014

Influenza Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Influenza from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Influenza medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Influenza medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Influenza medical therapy

CDC on Influenza medical therapy

Influenza medical therapy in the news

Blogs on Influenza medical therapy

Directions to Hospitals Treating Influenza

Risk calculators and risk factors for Influenza medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Medical Therapy

Antiviral Medications

  • Antiviral medications with activity against influenza viruses are an important adjunct to influenza vaccine in the control of influenza.
  • Influenza antiviral prescription drugs can be used to treat influenza or to prevent influenza.
  • Four licensed prescription influenza antiviral agents are available in the United States.
  • Two FDA-approved influenza antiviral medications are recommended for use in the United States during the 2013-2014 influenza season:
  • Oral oseltamivir (Tamiflu®)
  • Inhaled zanamivir (Relenza®)
  • Oseltamivir and zanamivir are chemically related antiviral medications known as neuraminidase inhibitors that have activity against both influenza A and B viruses.
  • Amantadine and rimantadine are antiviral drugs in a class of medications known as adamantanes.
  • Amantadines are active against influenza A viruses, but not influenza B viruses.
  • As in recent past seasons, there is a high prevalence (>99%) of influenza A(H3N2) and influenza A(H1N1)pdm09 (2009 H1N1) viruses resistant to adamantanes.
  • Therefore, amantadine and rimantadine are not recommended for antiviral treatment or chemoprophylaxis of currently circulating influenza A viruses.
  • Antiviral resistance to oseltamivir and zanamivir among circulating influenza viruses is currently low, but this might change.
  • Also, antiviral resistance can emerge during or after treatment in certain patients, such as immunosuppressed individuals.

Antiviral Medications Recommended for Treatment and Chemoprophylaxis of Influenza

Antiviral Agent Activity Against Use Recommended For Not Recommended for Use in Adverse Reactions
Oseltamivir (Tamiflu®) Influenza A and B Treatment Any age N/A Nausea, vomiting. Sporadic, transient neuropsychiatric events (self injury or delirium) mainly reported among Japanese adolescents and adults.
Prophylaxis > 3 months of age N/A
Zanamivir (Relenza®) Influenza A and B Treatment > 7 years old Patients with underlying respiratory disease, such as asthma or COPD Allergic reactions such as oropharyngeal or facial edema. Diarrhea, nausea, sinusitis, nasal signs and symptoms, bronchitis, cough, headache, dizziness, and ear, nose and throat infections.
Prophylaxis > 5 years old Patients with underlying respiratory disease, such as asthma or COPD
Table adapted from CDC [1]

Symptomatic Therapy

Over the counter (OTC) medicines may be taken to relieve influenza symptoms, but they do not affect the virus. [2]

Symptom(s) OTC Medicine
Fever, Aches, Pains, Sinus pressure, Sore throat Analgesics
Nasal congestion, Sinus pressure Decongestants
Sinus pressure, Runny nose, Watery eyes, Cough Antihistamines
Cough Cough suppressant
Sore throat Local anesthetics
  • Children and teenagers with flu symptoms (particularly fever) should avoid taking aspirin as taking aspirin in the presence of influenza infection (especially Influenzavirus B) can lead to Reye's syndrome, a rare but potentially fatal disease of the liver.[3]

Unconventional treatment

Homeopathic and other cold and flu remedies that fail to meet the regulatory requirements as drugs that treat disease, or the standards of evidence-based medicine, are sold as nutritional supplements.

They may be based on extracts of living things, but may lack documentation of their safety and effectiveness.

References

  1. "CDC Influenza Antiviral Medications: Summary for Clinicians".
  2. "Cold and Flu Guidelines: Influenza". American Lung Association. Retrieved 2007-09-16.
  3. Molotsky, Irvin (1986-02-15). "Consumer Saturday - Warning on Flu and Aspirin". New York Times. Retrieved 2007-05-25.

Template:WH Template:WS